Back to Companies
Gain Therapeutics, Inc.
GANXNasdaqCIK: 0001819411
Gain Therapeutics, Inc. (GANX) shows 10 recent insider filings from 9 insiders, with no open-market buying or selling. Mack Gene (CEO, President, Director) is the most active by dollar volume, and the single largest transaction was $372.0K by Mack Gene. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$871.7K
Purchases
$0
Sales
$0
Unique Insiders
9
Recent Insider Trades
10 loaded
| Oct 30 | GANX Gain Therapeutics, Inc. | Weidner Jeanette | See Remarks | Award | $154.7K |
| Oct 30 | GANX Gain Therapeutics, Inc. | Weidner Jeanette | See Remarks | Other | $0 |
| Jul 17 | GANX Gain Therapeutics, Inc. | GOLDSTEIN DOV A MD | Director | Award | $42.0K |
| Jul 17 | GANX Gain Therapeutics, Inc. | Melincoff Gwen A | Director | Award | $42.0K |
| Jul 17 | GANX Gain Therapeutics, Inc. | Nicaise Claude | Director | Award | $42.0K |
| Jul 17 | GANX Gain Therapeutics, Inc. | Islam Khalid | Director | Award | $42.0K |
| Jul 17 | GANX Gain Therapeutics, Inc. | Riley Jeffrey Scott | Director | Award | $42.0K |
| Jul 17 | GANX Gain Therapeutics, Inc. | HASLER HANS PETER | Director | Award | $42.0K |
| Mar 26 | GANX Gain Therapeutics, Inc. | Fuggetta Gianluca | See Remark | Award | $93.0K |
| Mar 26 | GANX Gain Therapeutics, Inc. | Mack Gene | CEO, President, Director | Award | $372.0K |
10 filings